Increased plasma levels of soluble P-selectin in rheumatic mitral stenosis

Chest

Volumn 126, Issue 1, 2004, Pages 54-58

  Chen, Mien Cheng ^a   Chang, Hsueh Wen ^b   Juang, Shyh Shiann ^c   Yip, Hon Kan ^a   Wu, Chiung Jen ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^c CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

Author keywords

Mitral stenosis; P selectin

Indexed keywords

PADGEM PROTEIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; ENZYME IMMUNOASSAY; FEMALE; FEMORAL ARTERY; FEMORAL VEIN; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART LEFT ATRIUM PRESSURE; HEART RIGHT ATRIUM; HUMAN; MALE; MITRAL VALVE; MITRAL VALVE STENOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINUS RHYTHM; THROMBOCYTE ACTIVATION; VALVULOPLASTY;

EID: 3242685311     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.126.1.54     Document Type: Article

References (15)

1. Stenberg PE, Mcever RP, Shuman MA, et al. A platelet α-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol 1985; 101:880-886
2. Berman CL, Yeo EL, Wencel-Drake JD, et al. A platelet α-granule membrane protein that is associated with the plasma membrane after activation. J Clin Invest 1986; 78:130-137
3. Cox D. Methods for monitoring platelet function. Am Heart J 1998; 135:S161-S169
4. Kunishjma S, Hattor M, Kobayashi S, et al. Activation and destruction platelets in patients with rheumatic heart disease. Eur Heart J 1994; 15:335-338
5. Steele PP, Weily HS, Davies H, et al. Platelet survival in patients with rheumatic heart disease. N Engl J Med 1974; 290:537-539
6. Chen MC, Wu CJ, Yip HK, et al. Left atrial platelet activity with rheumatic mitral stenosis: correlation study of severity and platelet P-selectin expression by flow cytometry. Chest 2003; 124:1663-1669
7. Li-Saw-Hee L, Blann AD, Goldsmith I, et al. Indexes of hypercoagulability measured in peripheral blood reflect levels in intracardiac blood in patients with atrial fibrillation secondary to mitral stenosis. Am J Cardiol 1999; 83:1206-1209
8. Goldsmith I, Li-Saw-Hee L, Blann AD, et al. Increased platelet activation and endothelial dysfunction in patients with atrial fibrillation immediately following percutaneous balloon mitral valvuloplasty. Clin Cardiol 2000; 23:587-590
9. Hung JS, Chern MS, Wu JJ, et al. Short- and long-term results of catheter balloon percutaneous transvenous mitral commissurotomy. Am J Cardiol 1991; 67:854-862
10. Angleton P, Chandler WL, Schmer G. Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1). Circulation 1989; 79:101-106
11. Kovacs IB, Murphy M, Barin E, et al. Effect of warfarin on arterial thrombogenesis: problems on monitoring. Am J Hematol 1993; 42:322-327
12. Mieszczak C, Winther K. Does warfarin enhance platelet activity? Eur J Clin Pharmacol 1996; 84:285-287
13. Schneider DJ, Tracy PB, Mann KG, et al. Differential effects of anticoagulants on the activation of platelets ex vivo. Circulation 1997; 96:2877-2883
14. Chen MC, Wu CJ, Yip HK, et al. Increased circulating endothelin-1 in rheumatic mitral stenosis: irrelevance to left atrial and pulmonary artery pressures. Chest 2004; 125:390-396
15. Yamamoto K, Ikeda U, Mito H, et al. Endothelin production in pulmonary circulation of patients with mitral stenosis. Circulation 1994; 89:2093-2098